Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 536.60
+16.00 (3.07%)
At close: Nov 26, 2025
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 37.72 billion as of November 26, 2025. Its market cap has decreased by -36.97% in one year.
Market Cap
37.72B
Enterprise Value
21.95B
Revenue
9.16B
Ranking
n/a
PE Ratio
5.86
Stock Price
536.60
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 37.72B, an increase of 2,583.04%. That is a compound annual growth rate of 24.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 37.72B | -25.39% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | 8.77B | 3.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.35T |
| Coloplast | 130.76B |
| Genmab | 123.50B |
| ALK-Abelló | 50.48B |
| Demant | 45.76B |
| H. Lundbeck | 41.67B |
| Ambu A/S | 23.44B |
| Bavarian Nordic | 14.56B |